In vitro revascularization of tumors
Scope:
Internacional
Financing entity:
Miltenyi Biotech GmbH
Contracting entities:
Miltenyi Biotech GmbH
Principal researcher:
Pedro Baptista
Contract managing entity:
Otros
Number of researchers:
2
NABS code:
13.3 I+D en relación con las Ciencias médicas
Start date:
10/2017
End date:
10/2022